Browse regulations

Sets uniform standards and processes for determining allowable costs in Legal Services Corporation (LSC) grants, defining allowable, reasonable, and allocable costs, requiring prior approval for certain expenditures, establishing procedures for questioning and appealing disallowed costs, and detailing closeout requirements.

Imposes heavy compliance burdens on legal aid organizations, especially smaller ones, diverting scarce resources from serving low-income clients. Duplicates broader federal cost principles (OMB Uniform Guidance) and micromanages grant expenditures, stifling flexibility and innovation. The hidden tax of compliance reduces program effectiveness while protecting incumbent large organizations, raising barriers to entry and contradicting free enterprise principles.

Requires Legal Services Corporation (LSC) recipients to maintain fidelity bond coverage or similar insurance equal to at least 10% of their annual funding (minimum $100,000) to protect against fraudulent or dishonest acts by employees, officers, directors, agents, volunteers, and third-party contractors handling LSC funds.

Imposes a compliance burden on legal aid organizations for a risk management practice that any prudent entity would undertake voluntarily as standard fiduciary duty. Federal taxpayers would not be materially worse off if repealed because: (1) recipients already have strong incentives to protect their funding from fraud, (2) existing criminal laws and audit requirements provide adequate safeguards, and (3) bonding costs would still be incurred as a legitimate business expense even without the mandate. The regulation merely creates administrative overhead to verify compliance with what should be a private market decision, diverting resources from actual legal services to low-income Americans.

Regulation establishes requirements for subgrants of Legal Services Corporation (LSC) federal funds from recipients to third parties, including definitions, substance-over-form test for subgrant vs procurement, $20,000 prior-approval threshold, duration limits (1 year for basic grants), oversight provisions, recordkeeping, audit obligations, and restrictions mirroring those on recipients.

Imposes significant compliance costs and administrative barriers that reduce legal aid efficiency. The $20,000 prior-approval threshold creates arbitrary hurdles delaying service delivery and centralizes decisions away from local providers who understand community needs. Oversight and audit requirements consume resources better spent on actual client services. Federal involvement in legal aid funding represents unconstitutional Tenth Amendment overreach, distorting the market and crowding out private charitable solutions. Unseen consequences include reduced competition, bureaucratic mission creep, and moral hazard as recipients bear liability for subrecipient actions—classic regulatory burden that protects incumbents while claiming to serve the poor.

Definitions section for Legal Services Corporation (LSC) regulations - defines key terms like eligible client, legal assistance, recipient, Corporation funds, etc. without imposing substantive requirements.

This is a pure definitions section with zero compliance burden; it merely clarifies terminology used elsewhere. Deleting it would create ambiguity in the substantive regulations it supports but would not reduce regulatory costs. The underlying LSC program itself warrants examination, but this ancillary ruleset has no independent effect.

Federal Common Rule regulates human subjects research funded or otherwise subject to federal oversight. Requires IRB review, defines human subjects, outlines exemptions, and mandates institutional assurances and certifications with detailed compliance timelines and waiver procedures.

Imposes massive administrative costs on research institutions, diverting billions from actual discovery. Compliance burden is especially heavy on small academic labs and startups, reducing competition and innovation. Unseen effects include delayed life-saving studies, risk-averse IRBs that block socially valuable research, and a culture that prioritizes paperwork over genuine ethical protection. The regulation assumes federal micromanagement is necessary, but professional ethics, tort liability, and institutional accountability can protect subjects without centralized control.

Defines personal injury and severe personal injury for claim purposes, sets a one-year filing deadline for Guam WWII Loyalty Recognition Act claims after notice publication, and incorporates specific procedural sections from subchapter C.

Deletion would leave claimants without clear guidelines, risking inconsistent decisions and denied justice; the regulation provides essential structure, fairness, and efficiency that would be hard to replicate, ensuring the Act's promises are fulfilled.

Federal regulation governing all research involving human subjects conducted, supported, or regulated by federal agencies. Requires institutions to obtain IRB approval, provide written assurances, secure informed consent, and comply with extensive procedural requirements. Contains numerous exemption categories, waiver provisions, and transition rules, creating a complex bureaucratic framework that applies nationwide and even to foreign research receiving U.S. funding.

Imposes crushing compliance costs and bureaucratic delays on medical research, stifling innovation and raising healthcare costs; represents federal overreach into areas properly regulated by states under the Tenth Amendment; one-size-fits-all approach fails to recognize varying risk levels, disproportionately harming small research institutions and delaying life-saving treatments. The ethical goals can be achieved through less costly means including state regulation, professional standards, and tort law.

Regulation creates federal qualification standards for appraisers of Native American trust/restricted property, establishing a voluntary expedited pathway where appraisals are accepted without Departmental review if the appraiser holds a state Certified General Appraiser license, meets USPAP standards, and submits qualification documentation.

Imposes unnecessary federal barriers to entry that raise appraisal costs, reduce competition, and burden small tribes and individual Indians. Violates subsidiarity by supplanting state licensing and tribal sovereignty—tribes could establish their own standards contractually. The compliance paperwork and rigid USPAP mandate create deadweight loss without improving outcomes, while centralizing knowledge in Washington prevents market-driven innovation. The trust responsibility is better served by tribal autonomy than by one-size-fits-all bureaucratic credentialing.

This regulation implements the 340B drug pricing program, requiring manufacturers to sell covered outpatient drugs to specified 'covered entities' (e.g., safety-net clinics) at discounted ceiling prices calculated from Average Manufacturer Price minus rebate amount. It establishes an Administrative Dispute Resolution process for resolving overcharge claims and violations, with penalties and a multi-tiered review mechanism.

The 340B price controls impose heavy compliance costs on manufacturers (quarterly price calculations, audits, dispute resolution) and distort drug markets, potentially reducing supply and innovation. The complex ADR bureaucracy adds hidden tax burdens while undermining rule of law. Federal overreach into private pricing violates Tenth Amendment principles. Intended benefits for safety-net providers can be achieved more efficiently through direct subsidies or Medicaid expansions without market distortions.

These regulations (42 CFR Part 2) protect the confidentiality of substance use disorder patient records from federally assisted treatment programs. They prohibit use or disclosure without patient consent except for specific circumstances including court orders, medical emergencies, research, and audits. The goal is to encourage treatment-seeking by ensuring patients won't be made more vulnerable by their records than those who don't seek treatment.

Deleting these protections would deter individuals from seeking life-saving substance use disorder treatment due to fear of prosecution, employment discrimination, or other harms. The regulation achieves its goal through mandatory, uniform privacy standards that create trust in the treatment system—trust that would be difficult to replicate through variable state laws or private contracts, leading to worse public health outcomes and greater societal costs from untreated addiction.

Regulation establishes CSB's FOIA implementation procedures, defining roles (FOIA Officer, Chief FOIA Officer), request processing methods, exemptions from disclosure, fee structures, and interagency coordination protocols.

Deleting these regulations would create uncertainty and arbitrary procedures for accessing CSB records, undermining transparency and accountability. The structured framework balances public access with legitimate exemptions (national security, privacy, trade secrets) while enabling citizens to monitor an agency responsible for chemical safety investigations—a clear benefit that outweighs the minimal administrative burden.

EPA Test Guideline specifying detailed laboratory procedures for measuring chemical properties: UV-VIS absorption spectra (photochemical degradation potential), vapor pressure (isoteniscope and gas saturation methods), and soil/sediment adsorption isotherns. Mandates specific equipment, calibration standards, and reporting formats for chemical fate testing.

$2 trillion regulatory burden includes these micro-management lab procedure mandates. The government should not prescribe exact scientific methodologies—private standards bodies (ASTM, ISO) already provide consensus methods. This raises barriers to entry for small chemical companies, stifles methodological innovation, and represents unconstitutional federal overreach into what should be state-regulated or privately-coordinated scientific practice. The data itself may be valuable, but mandating specific techniques achieves no public purpose that voluntary standardization wouldn't handle better.

This EPA regulation establishes a standardized laboratory protocol for measuring the indirect photoreaction rate constants of chemicals in natural waters containing humic substances. It specifies a three-phase process: (1) preparing synthetic humic water from Aldrich humic acid with precise pH, photobleaching, and absorbance standards; (2) screening test to determine if indirect photolysis is significant; (3) detailed measurement using the PNAP/PYR actinometer system to calculate kIE and kpE under specific seasonal and latitude conditions. The protocol dictates exact chemical concentrations, equipment (12×100mm quartz tubes with Mininert valves), irradiation geometry (30° north-facing), analytical methods (HPLC/GC), and complex computational corrections for photobleaching and solar irradiance variation.

This hyper-technical regulatory mandate micromanages laboratory methodology, imposing significant compliance costs and stifling scientific innovation. The federal government has no constitutional authority to dictate precise experimental protocols—this belongs to professional scientific societies via voluntary consensus standards (ASTM, ANSI). The regulation creates barriers to entry for small testing labs, locks in outdated methods (e.g., Mininert valves, specific humic sources), and prevents competitive evolution of more efficient techniques. EPA could achieve identical data quality by referencing voluntary standards or establishing performance-based criteria (e.g., accuracy ±5%) rather than prescribing exact procedures. The hidden tax of federal regulatory control here is unjustified when states or private accreditors can ensure reliability without central planning.

Requires manufacturers, importers, and processors to report chemical substance information to EPA for the TSCA Inventory via electronic forms (Form A/B), maintaining records and designating active/inactive status, with exemptions for R&D, naturally occurring substances, and byproducts.

Imposes substantial compliance costs and recordkeeping burdens, especially on small businesses; creates informational advantage for large incumbents; feeds regulatory overreach; and the inventory data could be gathered voluntarily or through commercial databases without coercive reporting, eliminating a hidden tax on Americans.

Regulation requires dental facilities discharging wastewater to POTWs to install and maintain amalgam separators or equivalent devices with at least 95% removal efficiency, implement best management practices, and submit reports, with exemptions for certain specialties, mobile units, and non-amalgam users.

Imposes significant compliance costs on small dental practices for controlling mercury from a minor pollution source, with unclear net benefits; federal overreach into local wastewater issues and could be better addressed by state regulation or market-based incentives, burdening small businesses and raising consumer costs.